High court ruling on gene patents lifts Myriad
Thursday, June 13, 2013 - 12:36
in Mathematics & Economics
Shares of diagnostic test maker Myriad Genetics Inc. are jumping Thursday after the Supreme Court issued a mixed ruling in a case involving the company's patents on genes at the center of its tests for increased risk of breast and ovarian cancer.